The DOI matches its Crossref record; 303 of the 303 references it cites were found in a registry or an index.
Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines
Open accessAbstract
BACKGROUND: Opioid use, abuse, and adverse consequences, including death, have escalated at an alarming rate since the 1990s. In an attempt to control opioid abuse, numerous regulations and guidelines for responsible opioid prescribing have been developed by various organizations. However, the US opioid epidemic is continuing and drug dose deaths tripled during 1999 to 2015. Recent data show a continuing increase in deaths due to natural and semisynthetic opioids, a decline in methadone deaths, and an explosive increase in the rates of deaths involving other opioids, specifically heroin and illicit synthetic fentanyl. Contrary to scientific evidence of efficacy and negative recommendations, a significant proportion of physicians and patients (92%) believe that opioids reduce pain and a smaller proportion (57%) report better quality of life. In preparation of the current guidelines, we have focused on the means to reduce the abuse and diversion of opioids without jeopardizing access for those patients suffering from non-cancer pain who have an appropriate medical indication for opioid use. OBJECTIVES: To provide guidance for the prescription of opioids for the management of chronic non-cancer pain, to develop a consistent philosophy among the many diverse groups with an interest in opioid use as to how appropriately prescribe opioids, to improve the treatment of chronic non-cancer pain and to reduce the likelihood of drug abuse and diversion. These guidelines are intended to provide a systematic and standardized approach to this complex and difficult arena of practice, while recognizing that every clinical situation is unique. METHODS: The methodology utilized included the development of objectives and key questions. The methodology also utilized trustworthy standards, appropriate disclosures of conflicts of interest, as well as a panel of experts from various specialties and groups. The literature pertaining to opioid use, abuse, effectiveness, and adverse consequences was reviewed, with a best evidence synthesis of the available literature, and utilized grading for recommendation as described by the Agency for Healthcare Research and Quality (AHRQ).Summary of Recommendations:i. Initial Steps of Opioid Therapy 1. Comprehensive assessment and documentation. (Evidence: Level I; Strength of Recommendation: Strong) 2. Screening for opioid abuse to identify opioid abusers. (Evidence: Level II-III; Strength of Recommendation: Moderate) 3. Utilization of prescription drug monitoring programs (PDMPs). (Evidence: Level I-II; Strength of Recommendation: Moderate to strong) 4. Utilization of urine drug testing (UDT). (Evidence: Level II; Strength of Recommendation: Moderate) 5. Establish appropriate physical diagnosis and psychological diagnosis if available. (Evidence: Level I; Strength of Recommendation: Strong) 6. Consider appropriate imaging, physical diagnosis, and psychological status to collaborate with subjective complaints. (Evidence: Level III; Strength of Recommendation: Moderate) 7. Establish medical necessity based on average moderate to severe (≥ 4 on a scale of 0 - 10) pain and/or disability. (Evidence: Level II; Strength of Recommendation: Moderate) 8. Stratify patients based on risk. (Evidence: Level I-II; Strength of Recommendation: Moderate) 9. Establish treatment goals of opioid therapy with regard to pain relief and improvement in function. (Evidence: Level I-II; Strength of Recommendation: Moderate) 10. Obtain a robust opioid agreement, which is followed by all parties. (Evidence: Level III; Strength of Recommendation: Moderate)ii. Assessment of Effectiveness of Long-Term Opioid Therapy 11. Initiate opioid therapy with low dose, short-acting drugs, with appropriate monitoring. (Evidence: Level II; Strength of Recommendation: Moderate) 12. Consider up to 40 morphine milligram equivalent (MME) as low dose, 41 to 90 MME as a moderate dose, and greater than 91 MME as high dose. (Evidence: Level II; Strength of Recommendation: Moderate) 13. Avoid long-acting opioids for the initiation of opioid therapy. (Evidence: Level I; Strength of Recommendation: Strong) 14. Recommend methadone only for use after failure of other opioid therapy and only by clinicians with specific training in its risks and uses, within FDA recommended doses. (Evidence: Level I; Strength of Recommendation: Strong) 15. Understand and educate the patients of the effectiveness and adverse consequences. (Evidence: Level I; Strength of Recommendation: Strong) 16. Similar effectiveness for long-acting and short-acting opioids with increased adverse consequences of long-acting opioids. (Evidence: Level I-II; Strength of recommendation: Moderate to strong) 17. Periodically assess pain relief and/or functional status improvement of ≥ 30% without adverse consequences. (Evidence: Level II; Strength of recommendation: Moderate) 18. Recommend long-acting or high dose opioids only in specific circumstances with severe intractable pain. (Evidence
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–303 of 303
O'Donnell, J., Ekman, E., Spalding, W., Bhadra, P., McCabe, D., & Berger, M. F. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700615 · Cited by 81
Birke, H., Kurita, G. P., Sjøgren, P., Højsted, J., Simonsen, M. K., Juel, K., & Ekholm, O. (2016) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12700 · Cited by 78
Doctor Shopping Reveals Geographical Variations in Opioid Abuse
Micallef, J. (2013) · Pain Physician · doi:10.36076/ppj.2013/16/89 · Cited by 77
House, P. A. (2009) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(09)79066-0 · Cited by 77
Pregabalin for acute and chronic pain in adults
Wiffen, P. J., Straube, S., Derry, S., Moore, R. A., & McQuay, H. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007076 · Cited by 77
Monitoring Opioid Adherence in Chronic Pain Patients: Assessment of Risk of Substance Misuse
Solanki, D. R., Koyyalagunta, D., Shah, R. V., Silverman, S. M., & Manchikanti, L. (2011) · Pain Physician · doi:10.36076/ppj.2011/14/e119 · Cited by 76
Self-citationBarry, L. C., Guo, Z., Kerns, R. D., Duong, B. D., & Reid, M. C. (2003) · Pain · doi:10.1016/s0304-3959(02)00471-2 · Cited by 76
Manchikanti, L. (2011) · Pain Physician · doi:10.36076/ppj.2011/14/175 · Cited by 75
Self-citationJones, C. M., Baldwin, G. T., Manocchio, T., White, J. O., & Mack, K. A. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6526a2 · Cited by 74
Wilder, C. M., Miller, S. C., Tiffany, E., Winhusen, T. M., Winstanley, E. L., & Stein, M. D. (2015) · Journal of Addictive Diseases · doi:10.1080/10550887.2016.1107264 · Cited by 72
Predictors of Long-Term Opioid Use Among Patients With Painful Lumbar Spine Conditions
Krebs, E. E., Lurie, J. D., Fanciullo, G. J., Tosteson, T. D., Blood, E., Carey, T. S., & Weinstein, J. N. (2009) · Journal of Pain · doi:10.1016/j.jpain.2009.05.007 · Cited by 71
Mayet, S., Gossop, M., Lintzeris, N., Markides, V., & Strang, J. (2011) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00237.x · Cited by 70
Leong, I., Farrell, M. J., Helme, R. D., & Gibson, S. J. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.5.550 · Cited by 70
Martins, S. S., Sampson, L., Cerdá, M., & Galea, S. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302843a · Cited by 70
Prolonged Opioid Use After Knee Arthroscopy in Military Veterans
Rozet, I., Nishio, I., Robbertze, R., Rotter, D., Chansky, H., & Hernandez, A. V. (2014) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000292 · Cited by 69
Manchikanti, L. (2005) · Pain Physician · doi:10.36076/ppj.2005/8/257 · Cited by 68
Self-citationNonsteroidal Anti‐Inflammatory Drugs, Gastroprotection, and Benefit–Risk
Moore, R. A., Derry, S., Simon, L. S., & Emery, P. (2013) · Pain Practice · doi:10.1111/papr.12100 · Cited by 67
Scherrer, J. F., Salas, J., Sullivan, M. D., Schneider, D., Bucholz, K. K., Burroughs, T. E., Copeland, L. A., Ahmedani, B. K., & Lustman, P. J. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.08.003 · Cited by 67
Fama, C., Chen, N., Prusik, J., Kumar, V., Wilock, M. E., Roth, S. G., & Pilitsis, J. G. (2016) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12434 · Cited by 66
Manchikanti, L. (2016) · Pain Physician · doi:10.36076/ppj/2019.19.e531 · Cited by 66
Self-citationAssessing Risk for Drug Overdose in a National Cohort: Role for Both Daily and Total Opioid Dose?
Liang, Y., & Turner, B. J. (2014) · Journal of Pain · doi:10.1016/j.jpain.2014.11.007 · Cited by 63
Kothe, R., Kohlmann, T., Klink, T., Rüther, W., & Klinger, R. (2006) · Pain · doi:10.1016/j.pain.2006.08.011 · Cited by 63
Häuser, W., Petzke, F. W., Radbruch, L., & Tölle, T. R. (2016) · Pain Management · doi:10.2217/pmt.16.5 · Cited by 62
Cervical zygapophysial (facet) joint pain: effectiveness of interventional management strategies
Manchikanti, L., Hirsch, J. A., Kaye, A. D., & Boswell, M. V. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2016.1105092 · Cited by 61
Self-citationSleep disturbance in patients taking opioid medication for chronic back pain
Robertson, J., Purple, R. J., Cole, P., Zaiwalla, Z., Wulff, K., & Pattinson, K. T. S. (2016) · Anaesthesia · doi:10.1111/anae.13601 · Cited by 60
A Systematic Evaluation of Burst Spinal Cord Stimulation for Chronic Back and Limb Pain
Hou, S., Kemp, K., & Grabois, M. (2016) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12440 · Cited by 59
Spector, W. D., Shaffer, T., Potter, D. E. B., Correa‐de‐Araujo, R., & Limcangco, M. R. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01081.x · Cited by 58
Duarte, R. V. (2015) · Pain Physician · doi:10.36076/ppj.2015/18/e369 · Cited by 58
Opioid-associated central sleep apnea: a case series
Alattar, M., & Scharf, S. M. (2008) · Sleep And Breathing · doi:10.1007/s11325-008-0221-7 · Cited by 57
A Systematic Review on the Treatment of Phantom Limb Pain with Spinal Cord Stimulation
Aiyer, R., Barkin, R. L., Bhatia, A., & Güngör, S. (2016) · Pain Management · doi:10.2217/pmt-2016-0041 · Cited by 57
Yarborough, B. J. H., Stumbo, S. P., Janoff, S. L., Yarborough, M. T., McCarty, D. W., Chilcoat, H. D., COPLAN, P. M., & Green, C. A. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.07.024 · Cited by 56
Fischer, B. (2015) · Pain Physician · doi:10.36076/ppj.2015/18/e605 · Cited by 55
Fanciullo, G. J., Ball, P. A., Girault, G., Rose, R. J., Hanscom, B. S., & Weinstein, J. N. (2002) · Spine · doi:10.1097/00007632-200201150-00016 · Cited by 55
Garg, R. K., Fulton‐Kehoe, D., Turner, J. A., Bauer, A. M., Wickizer, T. M., Sullivan, M. D., & Franklin, G. M. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.08.001 · Cited by 54
Manchikanti, L., Hirsch, J. A., Heavner, J. E., Cohen, S. P., Benyamin, R. M., Sehgal, N., Falco, F. J. E., Vallejo, R., Onyewu, O., Zhu, J., et al. (2014) · Pain Physician · doi:10.36076/ppj.2014/17/e291 · Cited by 54
Self-citationCloutier, C., Taliano, J., O’Mahony, W. F., Csanadi, M., Cohen, G., Sutton, I., Sinclair, D. M., Awde, M., Henein, S., Robinson, L. R., et al. (2013) · Pain Research and Management · doi:10.1155/2013/164609 · Cited by 53
Candiotti, K., & Gitlin, M. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.483941 · Cited by 53
Opioide bei chronischen nicht-tumorbedingten Schmerzen – sind sie Nichtopioidanalgetika überlegen?
Welsch, P., Sommer, C., Schiltenwolf, M., & Häuser, W. (2014) · Der Schmerz · doi:10.1007/s00482-014-1436-0 · Cited by 52
Manchikanti, L., Pampati, V., Fellows, B., Rivera, J. J., Damron, K. S., Beyer, C. D., & Cash, K. A. (2001) · Pain Physician · doi:10.36076/ppj.2001/4/349 · Cited by 52
Self-citationAufdemkampe, G., Kiers, H., Stappaerts, K. H., Heneweer, H., & van Tulder, M. W. (2007) · Data Archiving and Networked Services (DANS) · Cited by 51
Manchikanti, L., Helm, S., Pampati, V., & Racz, G. B. (2014) · Pain Practice · doi:10.1111/papr.12195 · Cited by 51
Self-citationOpioids In Chronic Noncancer Pain: Have We Reached A Boiling Point Yet?
Manchikanti, L. (2014) · Pain Physician · doi:10.36076/ppj.2014/17/e1 · Cited by 50
Self-citationFaour, M., Anderson, J. T., Haas, A. R., Percy, R., Woods, S. T., Ahn, U. M., & Ahn, N. U. (2016) · Spine · doi:10.1097/brs.0000000000001715 · Cited by 50
Manchikanti, L. (2002) · Pain Physician · doi:10.36076/ppj.2002/5/275 · Cited by 50
Self-citationRhee, Y., Taitel, M., Walker, D. R., & Lau, D. T. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.12.006 · Cited by 49
Manchikanti, L. (2013) · Pain Physician · doi:10.36076/ppj.2013/16/e1 · Cited by 47
Self-citationHarms of prescription opioid use in the United States
Imtiaz, S., Shield, K. D., Fischer, B., & Rehm, J. T. (2014) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-9-43 · Cited by 47
Manchikanti, L., Malla, Y., Wargo, B. W., & Fellows, B. (2011) · Pain Physician · doi:10.36076/ppj.2011/14/259 · Cited by 46
Self-citationAltier, N., Dion, D., Boulanger, A., & Choinière, M. (2001) · Burns · doi:10.1016/s0305-4179(01)00032-8 · Cited by 46
Methadone for Phantom Limb Pain
Bergmans, L., Snijdelaar, D. G., Katz, J. D., & Crul, B. J. P. (2002) · Clinical Journal of Pain · doi:10.1097/00002508-200205000-00012 · Cited by 46
Multimodal, Integrative Therapies for the Self-Management of Chronic Pain Symptoms
Lee, C., Crawford, C. C., Swann, S. I., & Active Self-Care Therapies for Pain (PACT) Working Group (2014) · Pain Medicine · doi:10.1111/pme.12408 · Cited by 45
Sparkes, E., Duarte, R. V., Mann, S. A., Lawrence, T. R., & Raphael, J. H. (2015) · PubMed · Cited by 44
Ultra-Low Dose Oral Naltrexone Decreases Side Effects and Potentiates the Effect of Methadone
Cruciani, R. A., Lussier, D., Miller-Saultz, D., & Arbuck, D. M. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00139-8 · Cited by 44
Sullivan, M. D., Bauer, A. M., Fulton‐Kehoe, D., Garg, R. K., Turner, J. A., Wickizer, T. M., & Franklin, G. M. (2016) · Journal of Pain · doi:10.1016/j.jpain.2015.12.018 · Cited by 44
Clarke, J. L., Skoufalos, A., & Scranton, R. E. (2016) · Population Health Management · doi:10.1089/pop.2015.0144 · Cited by 44
Current State of Opioid Therapy and Abuse
Manchikanti, L., Kaye, A. M., & Kaye, A. D. (2016) · Current Pain and Headache Reports · doi:10.1007/s11916-016-0564-x · Cited by 44
Self-citationHigh-risk Use by Patients Prescribed Opioids for Pain and its Role in Overdose Deaths
Quinlan, M. (2014) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2014.06.008 · Cited by 43
Hawkins, E. J., Malte, C. A., Grossbard, J. R., & Saxon, A. J. (2015) · Pain Medicine · doi:10.1111/pme.12787 · Cited by 43
A Framework for “Driving Under the Influence of Drugs” Policy for the Opioid Using Driver
Wilhelmi, B. G. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es215 · Cited by 40
Lessons learned in the abuse of pain-relief medication: a focus on healthcare costs
Manchikanti, L., Boswell, M., & Hirsch, J. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.33 · Cited by 40
Self-citationWu, P. C., Courtney Lang, P., Hasson, N. K., Linder, S. H., & Clark, J. D. (2011) · Journal of Opioid Management · doi:10.5055/jom.2010.0013 · Cited by 40
Does Opioid Pain Medication Use Affect the Outcome of Patients With Lumbar Disc Herniation?
Radcliff, K. E., Freedman, M. K., Hilibrand, A. S., Isaac, R., Lurie, J. D., Zhao, W., Vaccaro, A. R., Albert, T. J., & Weinstein, J. N. (2013) · Spine · doi:10.1097/brs.0b013e3182959e4e · Cited by 40
Bianchi, M., Broggini, M., Balzarini, P., Baratelli, E., Ferrario, P., Panerai, A. E., & Sacerdote, P. (2003) · International Immunopharmacology · doi:10.1016/j.intimp.2003.08.011 · Cited by 38
Garcia, A. M. (2013) · The Journal of Law Medicine & Ethics · doi:10.1111/jlme.12037 · Cited by 38
Manchikanti, L. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/145 · Cited by 38
Self-citationTransdermal Buprenorphine for the Treatment of Chronic Noncancer Pain in the Oldest Old
Gianni, W., Madaio, A. R., Ceci, M., et al. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2010.06.015 · Cited by 37
Gaither, J. R., Goulet, J. L., Becker, W. C., Crystal, S., Edelman, E. J., Gordon, K. S., Kerns, R. D., Rimland, D., Skanderson, M., Justice, A. C., et al. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3571-4 · Cited by 37
Tamper-resistant drugs cannot solve the opioid crisis
Leece, P., Orkin, A. M., & Kahan, M. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.150329 · Cited by 36
Davis, J. M., Severtson, S. G., Bucher‐Bartelson, B., & Dart, R. C. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3533 · Cited by 36
Manchikanti, L. (2004) · Pain Physician · doi:10.36076/ppj.2004/7/71 · Cited by 35
Self-citationBachhuber, M. A., Maughan, B. C., Mitra, N., Feingold, J., & Starrels, J. L. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2015.08.005 · Cited by 35
Miller, N. S., Swiney, T., & Barkin, R. L. (2006) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000212894.35705.90 · Cited by 32
Negative outcomes of unbalanced opioid policy supported by clinicians, politicians, and the media
Scholten, W., & Henningfield, J. E. (2016) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2015.1136368 · Cited by 32
Traeger, A. C., Hübscher, M., Henschke, N., Williams, C. M., Maher, C. G., Moseley, G. L., Lee, H., & McAuley, J. H. (2016) · European Spine Journal · doi:10.1007/s00586-016-4461-0 · Cited by 30
Boden, S. D., & Swanson, A. L. (1998) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/s1047-9651(18)30266-3 · Cited by 30
Methadone related deaths compared to all prescription related deaths
Lev, R., Petro, S., Lee, A., Lee, O., Lucas, J. R., Castillo, E. M., Egnatios, J., & Vilke, G. M. (2015) · Forensic Science International · doi:10.1016/j.forsciint.2015.09.021 · Cited by 28
Depressive symptoms in community-dwelling older adults receiving opioid therapy for chronic pain
Lavin, R. A., & Park, J. (2011) · Journal of Opioid Management · doi:10.5055/jom.2011.0072 · Cited by 28
Pascual, M. L. G., Fleming, R. R., Gana, T. J., & Vorsanger, G. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x233179 · Cited by 28
Blake, H., Leighton, P. A., van de Walt, G., & Ravenscroft, A. (2015) · British Journal of Pain · doi:10.1177/2049463715579284 · Cited by 28
Kirsh, K. L., & Fishman, S. M. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2010.00992.x · Cited by 27
Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia
Bhusal, S., Diomampo, S., & Magrey, M. (2016) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s95535 · Cited by 27
Pampati, S., & Manchikanti, L. (2016) · Pain Physician · doi:10.36076/ppj/2019.19.e569 · Cited by 26
Self-citationA Prospective Study of Predictors of Long-term Opioid Use Among Patients With Chronic Noncancer Pain
Thielke, S. M., Shortreed, S. M., Saunders, K. W., Turner, J. A., LeResche, L., & Korff, M. V. (2016) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000409 · Cited by 26
Weimer, M. B., & Chou, R. (2014) · Journal of Pain · doi:10.1016/j.jpain.2014.01.496 · Cited by 24
Physical Functioning and Opioid use in Patients with Neuropathic Pain
Bostick, G. P., Toth, C. C., Carr, E., Stitt, L., Morley-Forster, P., Clark, A. J., Lynch, M. E., GORDON, A. S., Nathan, H., Smyth, C. E., et al. (2015) · Pain Medicine · doi:10.1111/pme.12702 · Cited by 23
Opioids in the parturient with chronic nonmalignant pain: A retrospective review
Ibrahim Hadi, M., da Silva, O., Natale, R., Boyd, D. B., & Morley-Forster, P. (2006) · Journal of Opioid Management · doi:10.5055/jom.2006.0005 · Cited by 23
Pegram, S. E., Lumley, M. A., Jasinski, M. J., & Burns, J. W. (2016) · Annals of Behavioral Medicine · doi:10.1007/s12160-016-9838-0 · Cited by 23
Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective
Choy, E., Richards, S., Bowrin, K., Watson, P., Lloyd, A., Sadosky, A., & Zlateva, G. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003600271 · Cited by 22
Gold, L. S., Strassels, S. A., & Hansen, R. N. (2015) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000322 · Cited by 21
Tonosu, J., Oka, H., Matsudaira, K., Higashikawa, A., Okazaki, H., & Tanaka, S. (2016) · Journal of Pain Research · doi:10.2147/jpr.s122380 · Cited by 20
Office-Based Opioid Dependence Treatment
Colson, J. D. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es231 · Cited by 19
Functional Outcomes in Patients with Chronic Nonmalignant Pain on Long‐Term Opioid Therapy
Soin, A., Cheng, J., Brown, L. L., Moufawad, S., & Mekhail, N. A. (2008) · Pain Practice · doi:10.1111/j.1533-2500.2008.00233.x · Cited by 19
Recent Developments in Prescription Opioidrelated Dispensing and Harm Indicators in Ontario, Canada
Fischer, B. (2015) · Pain Physician · doi:10.36076/ppj.2015/18/e659 · Cited by 19
Description of Documentation in the Management of Chronic Spinal Pain
Manchikanti, L. (2009) · Pain Physician · doi:10.36076/ppj.2009/12/e199 · Cited by 17
Self-citationGuerriero, F., & Reid, M. C. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1254603 · Cited by 16
Opioid Contribution to Decreased Cortisol Levels in Critical Care Patients
Daniell, H. W. (2008) · Archives of Surgery · doi:10.1001/archsurg.143.12.1147 · Cited by 15
Clinical and psychological correlates of lumbar motion abnormalities in low back disorders
Cherniack, M. C., Dillon, C. F., Erdil, M., et al. (2001) · The Spine Journal · doi:10.1016/s1529-9430(01)00104-8 · Cited by 13
Preparing a prescription drug monitoring program data set for research purposes
O’Kane, N., Hallvik, S. E., Marino, M., Otterloo, J. V., Hildebran, C., Leichtling, G. J., & Deyo, R. A. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4039 · Cited by 13
The role of abuse-deterrent formulations in countering opioid misuse and abuse
Nguyen, V., Raffa, R. B., Taylor, R., & Pergolizzi, J. V. (2015) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12337 · Cited by 12
Pergolizzi, J. V., Raffa, R. B., & LeQuang, J. A. (2016) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12444 · Cited by 11
Zeidan, A. Z., Sayed, B. A., Bargaoui, N., DJEBBAR, M., Djennane, M., Donald, R., Deeb, K. E., Joudeh, R. A., Nabhan, A., & Schug, S. A. (2012) · Pain Practice · doi:10.1111/j.1533-2500.2012.00591.x · Cited by 10
Strategies for Flipping the Script on Opioid Overprescribing
Wright, A. P., Becker, W. C., & Schiff, G. D. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.5946 · Cited by 10
Abram, S. E. (2009) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/s1073-5437(09)79232-0 · Cited by 9
Cited by
Bruyère, O., Honvo, G., Veronese, N., Arden, N. K., Branco, J., Curtis, E. M., Al-Daghri, N. M., Herrero-Beaumont, G., Martel-Pelletier, J., Pelletier, J.-P., et al. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.04.008 · Cited by 695
Management of Musculoskeletal Pain: An Update with Emphasis on Chronic Musculoskeletal Pain
El-Tallawy, S. N., Nalamasu, R., Salem, G. I., LeQuang, J. A. K., Pergolizzi, J. V., & Christo, P. J. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00235-2 · Cited by 532
A brief history of the opioid epidemic and strategies for pain medicine
Jones, M. R., Viswanath, O., Peck, J., Kaye, A. D., Gill, J. S., & Simopoulos, T. T. (2018) · Pain and Therapy · doi:10.1007/s40122-018-0097-6 · Cited by 405
MECHANISMS OF ENDOCRINOLOGY: endocrinology of opioids
Fountas, A., Chai, S. T., Kourkouti, C., & Karavitaki, N. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0270 · Cited by 60
The opioid epidemic in pediatrics: a 2020 update
Yaster, M., McNaull, P. P., & Davis, P. J. (2020) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000865 · Cited by 56
Metadata
- Authors
- Manchikanti, L.
- Venue
- Pain Physician
- Published
- 2017-02-10
- Volume
- 2
- Issue
- 20;2
- Pages
- s3-s92
- ISSN
- 1533-3159 (ISSN-L)
- 2150-1149
- OpenAlex
- W2591605610
- Cited by
- 430
- References
- 303
- FWCI
- 58.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.